Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,171.00
(
0.71%
)
News Focus
News Focus

Replies to post #9625 on Amarantus Bioscience Holdings Inc (AMBS)

Replies to #9625 on Amarantus Bioscience Holdings Inc (AMBS)
icon url

cjstocksup

11/14/12 12:10 AM

#9626 RE: cjstocksup #9625

Dr. Rubinfeld: "...I believe that MANF could be one of the biggest successes that I have ever seen." From: http://www.sbwire.com/press-releases/amarantus-biosciences-inc-otc-ambs-what-a-stock-178166.htm

Guys, we have a tiger by the tail, no matter how you slice it. AMBS
icon url

cjstocksup

12/05/12 11:41 AM

#17177 RE: cjstocksup #9625

AMARANTUS BIOSCIENCES INC(OTC:AMBS) The Company has appointed Amgen Co-Founder Joseph Rubinfeld, PhD to its Corporate Advisory Board. Dr. Rubinfeld will assist management in positioning the Company's development programs for partnering, as well as provide guidance on MANF-based small molecule strategies with his extensive medicinal chemistry background.The Company is a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF.